Meditab Holdings Ltd
- All
- News
-
Cipla's Arm Meditab Sells Stake in Jiangsu for $18.5 Million
Drug major Cipla today said its Mauritius subsidiary Meditab Holdings has signed a deal to sell its entire 48.22 per cent stake in China-based Jiangsu Cdymax Pharmaceuticals for $18.5 million (over Rs 114 crore).
-
Cipla ups stake in Ugandan firm, acquires 14.5% for $15 million
Meditab Holdings Ltd (MHL), a wholly owned step down subsidiary of the company, has acquired an additional 14.5 per cent stake in QCIL, Cipla Ltd said in a filing to the BSE.
-
Cipla's Arm Meditab Sells Stake in Jiangsu for $18.5 Million
Drug major Cipla today said its Mauritius subsidiary Meditab Holdings has signed a deal to sell its entire 48.22 per cent stake in China-based Jiangsu Cdymax Pharmaceuticals for $18.5 million (over Rs 114 crore).
-
Cipla ups stake in Ugandan firm, acquires 14.5% for $15 million
Meditab Holdings Ltd (MHL), a wholly owned step down subsidiary of the company, has acquired an additional 14.5 per cent stake in QCIL, Cipla Ltd said in a filing to the BSE.
